MarketPeel
Insider Trading Intelligence
Pricing
…
CP

Christopher Brett Primiano

AURA
CHIEF BUSINESS OFFICER · AURA BIOSCIENCES, INC. · CIK 0001603510
FILING MIX · LIFETIME38%/62%
BUYS
12
SELLS
20
TOTAL VALUE
$6.29M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
13,273
AVG SELL PX
$18.29
TRADE KIND
SHOWING 32 / 32
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Christopher Brett Primiano, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+83.33%-8.54%-2.98%-5.55%-5.50%—
14d12+58.33%-4.56%-5.44%+0.88%-4.30%—
30d12+83.33%-10.16%-4.00%-6.16%-11.09%—
60d12+66.67%-4.86%+1.06%-5.92%-10.13%—
90d12+58.33%-13.88%+6.14%-20.02%-25.63%—
180d12+100.00%-35.36%+15.94%-51.30%-58.00%—
1y12+100.00%-54.04%+31.58%-85.62%-87.03%—
2y12+100.00%-65.71%+29.21%-94.93%-86.23%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AURA · 8,750 shares · as of Oct 28, 2021
09,37518,75028,12537,500SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
FLOW · 12 buys / 20 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
37,500——37,500Oct 28, 2021Oct 29, 2021 ↗
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
8,750——8,750Oct 28, 2021Oct 29, 2021 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
78,124$17.66$1.38M4,523Dec 1, 2020Dec 3, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
78,124——46,876Dec 1, 2020Dec 3, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
58,937$10.39$612.4K63,460Dec 1, 2020Dec 3, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
78,124$10.45$816.4K82,647Dec 1, 2020Dec 3, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
58,937——16,842Dec 1, 2020Dec 3, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
58,937$17.35$1.02M4,523Dec 1, 2020Dec 3, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
772$14.92$11.5K4,523Nov 2, 2020Nov 4, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
721$10.39$7.5K5,370Oct 13, 2020Oct 14, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
721$17.20$12.4K4,649Oct 13, 2020Oct 14, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
38,550——64,250Oct 13, 2020Oct 14, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
721——75,779Oct 13, 2020Oct 14, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
38,550$16.85$649.6K4,649Oct 13, 2020Oct 14, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
38,550$9.21$355.0K43,199Oct 13, 2020Oct 14, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
10,054——0Sep 8, 2020Sep 10, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
10,054$14.98$150.6K4,649Sep 8, 2020Sep 10, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
10,054$6.54$65.8K14,703Sep 8, 2020Sep 10, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
6,714$19.62$131.7K4,649May 7, 2020May 11, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
2,946$20.00$58.9K4,649May 7, 2020May 11, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
2,946——10,054May 7, 2020May 11, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
2,946$6.54$19.3K7,595May 7, 2020May 11, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
26,500——76,500Mar 2, 2020Mar 4, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
9,000$24.00$216.0K10,367Mar 2, 2020Mar 4, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
7,500$23.50$176.3K29,367Mar 2, 2020Mar 4, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
26,500$10.39$275.3K36,867Mar 2, 2020Mar 4, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
10,000$28.00$280.0K19,367Mar 2, 2020Mar 4, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
2,961$16.48$48.8K10,367Feb 19, 2020Feb 21, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASE
EVP, CBO, GC & Secretary
9,675——13,328Feb 15, 2020Feb 19, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
SALE
EVP, CBO, GC & Secretary
9,675——29,025Feb 15, 2020Feb 19, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
81,200——81,200Feb 5, 2020Feb 7, 2020 ↗
KPTI
KARYOPHARM THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
30,300——30,300Feb 5, 2020Feb 7, 2020 ↗
Other insiders · AURA
Loading peer insiders…
About this filer
CIK 0001603510
ROLE
Chief Business Officer
PRIMARY
AURA
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001603510DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback